Brand profile · Research Services

Cumming Global Centre for Pandemic Therapeutics

Melbourne, Victoria-based Cumming Global Centre for operates in Research Services. Ownership is a partnership; it publishes at doherty.edu.au. It holds one address on record, all in Australia. The record counts 8 people. It is listed alongside eight similar brands, mostly in Research Services.

Profile live Partnership Founded 2022 1 office country

Key facts

Counted staff
8
self-reported band not used
Founded
2022
4 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Partnership
self-reported
Use this profile Compare Your shortlist

Description

The world needs detection and diagnostics, vaccines and treatments delivered at speed and scale to control a pandemic. Our discovery research will advance the technologies and treatments we need to prepare for future pandemics and safeguard our future.

Effective therapeutics are critical in a pandemic. When we have safe, affordable and effective therapeutics, we can treat people when they are sick and reduce the severity of disease.

Our ambitious research program will accelerate the science behind therapeutics so they can be fast-tracked for us in the face of another pandemic. It will focus on:

  • Fundamental virology, bacteriology and immunology to identify new targets for treatment strategies
  • Platform technologies that can get new therapeutics into patients faster than traditional approaches
  • Innovative blue-sky research that will provide the foundation for more targeted research and practical applications.

The establishment of the Cumming Global Centre for Pandemic Therapeutics was made possible by the exceptional generosity of international businessman and philanthropist, Mr Geoffrey Cumming, who donated $250 million to the University of Melbourne to set up it up within the Doherty Institute.

The Victorian Government has also contributed significantly to the new world-leading centre, initially committing $75 million in recognition of the critical need to advance the science behind therapeutics.

Locations

Country footprint

Offices in 1 countryCountry footprint: 1 country, primary AU. Codes: AU.1 countryprimary AUAU
Show as table · Offices in 1 country
Offices in 1 country
Countries1
Primary countryAU

All codes: AU

Addresses

  • AU792 Elizabeth St; Melbourne, Victoria 3000Primary

Grid intelligence Members

Spending power

TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.

Spending power

Signals & hiring

Hiring, headcount and registry-change signals, streamed to members.

Latest signal
Hiring activity
Headcount trend

Financials

Registry-filed capital and financial indicators, standardised by TheGrid.

Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss

People & contacts

4 employee profiles on record · names withheld.

Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.

Counts only. No names are stored here, and none are served.

Notify me about contacts Tell us who you need to reach and we will tell you when a consented source is live.

FAQ

How many people work at Cumming Global Centre for Pandemic Therapeutics?

The record holds 8 counted staff profiles at January 2026. Its self-reported band sits above that count and is not published as a headcount.

Where does Cumming Global Centre for Pandemic Therapeutics have offices?

One address on record, Australia only. Primary: 792 Elizabeth St, Melbourne, Victoria 3000.

Has Cumming Global Centre for Pandemic Therapeutics raised funding?

None linked to this brand.

Which companies are listed alongside Cumming Global Centre for Pandemic Therapeutics?

Eight peer profiles on record: Garvan Institute of Medical Research and Translational Research Institute Australia.

What is Cumming Global Centre for Pandemic Therapeutics's website?